test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works

Advanced Search
& Collections
Issue Date   
Sign on to:   
Receive email
My Account
authorized users
Edit Profile   
About T-Space   

T-Space at The University of Toronto Libraries >
University of Toronto at Scarborough >
Bioline International Legacy Collection >
Bioline International Legacy Collection >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/22081

Title: BIOTECH R&D - Biotechnology Companies - Is the R&D Tax Offset a Genuine Option?
Authors: Muttilainen, Susanna
Issue Date: 31-Dec-2002
Publisher: AusBiotech
Citation: Australasian Biotechnology (backfiles) (ISSN: 1036-7128) Vol 12 Num 5
Abstract: This article is a follow up to our New Incentives for R&D - Recent Changes to R&D Tax Concession article published in the August/September 2002 edition of Australasian Biotechnology. In particular, this article focuses on the new R&D Tax Offset, which allows eligible companies to receive a cash rebate equivalent to the value of the R&D Tax Concession. This is an initiative welcomed by small companies across most industry sectors, encouraging higher levels of expenditure on R&D. However, there are concerns that some companies in the biotechnology sector will fail to qualify for the Offset because they are spending too much on eligible R&D activities or have an ownership structure that is in breach of the requirements. This article discusses these issues in detail as well as providing suggestions as to how the Offset might be made of value to more biotechnology companies.
URI: http://hdl.handle.net/1807/22081
Other Identifiers: http://www.bioline.org.br/abstract?id=au02031
Rights: Copyright 2002 - AusBiotech
Appears in Collections:Bioline International Legacy Collection

Files in This Item:

File Description SizeFormat
au02031.html14.98 kBHTMLView/Open

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.